Search results
Showing 31 to 45 of 70 results for crohn's disease
PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis (MIB313)
NICE has developed a medtech innovation briefing (MIB) on PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis .
NICE has developed a medtech innovation briefing (MIB) on Permacol for treating anal fistulae .
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184)
This guideline covers investigating and managing gastro-oesophageal reflux disease (GORD) and dyspepsia in people aged 18 and over. It aims to improve the treatment of GORD and dyspepsia by making detailed recommendations on Helicobacter pylori eradication, and specifying when to consider laparoscopic fundoplication and referral to specialist services.
NaviCam for diagnosing gastrointestinal tract conditions (MIB104)
NICE has developed a medtech innovation briefing (MIB) on NaviCam for diagnosing gastrointestinal tract conditions .
Evidence-based recommendations on endoscopic ablation for an anal fistula in adults. This involves applying heat to the fistula.
View recommendations for HTG506Show all sections
This quality standard covers diagnosing and managing spondyloarthritis in adults aged 16 and over. It describes high-quality care in priority areas for improvement.
Etrolizumab for previously treated moderately to severely active Crohn's disease [ID3965]
Discontinued Reference number: GID-TA10870
Evidence-based recommendations on Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal in adults. This involves using the ileum to create a pouch on the inside of the abdominal wall to collect waste.
View recommendations for HTG503Show all sections
This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.
NICE has developed a medtech innovation briefing (MIB) on VAAFT for treating anal fistulae .
Masitinib for previously treated moderate Crohn's disease [ID1239]
Discontinued Reference number: GID-TA11188
Summary of the evidence on infliximab for treating refractory extrapulmonary sarcoidosis to inform local NHS planning and decision-making
This guideline covers the diagnosis and management of diverticular disease in people aged 18 years and over. It aims to improve diagnosis and care and help people get timely information and advice, including advice about symptoms and when to seek help.
ADMIRE-CD II trial did not capture fully the relapsing-remitting nature of Crohn's disease with perianal fistulas. The new evidence...
history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas? Any explanatory notes(if...